RARE DISEASERESEARCH ATLAS

ORPHA:66630

Congenital pseudoarthrosis of the clavicle

high confidenceDisorder

Also known as: Congenital pseudarthrosis of the clavicle

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

149

49.6th percentile

Trials

0

Interventional, condition-specific

Researchers

496

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

Clinical definition (Orphanet)

A rare dysostosis of genetic origin characterized by a painless mass over the clavicle which is due to the failure of the union process of the ossification nuclei of the clavicle.

How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

congenital pseudarthrosis of the clavicle

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    149 matched papers (40 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

149

149 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

149 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

40 in the last 10 years · high confidence · 49.6th percentile (publications denominator)

Phrase hits: 149 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

496

Distinct author names in 149 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Sales de Gauzy J3 papers · 2024

    Service d'Orthopédie Pédiatrique, Hôpital Purpan, Toulouse, France.

    Papers in Europe PMC
  2. 02
    Waters PM3 papers · 2023

    Department of Orthopaedic Surgery, Children's Hospital, Boston, MA, USA.

    Papers in Europe PMC
  3. 03
    Abid A2 papers · 2024

    Université Toulouse 3, Paul-Sabatier, Toulouse, France; Département de chirurgie orthopédique, traumatologique et plastique pédiatrique, hôpital des enfants, CHU Toulouse, 330, avenue de Grande-Bretagne, 31059, France.

    Papers in Europe PMC
  4. 04
    Accadbled F2 papers · 2024

    Université Toulouse 3, Paul-Sabatier, Toulouse, France; Département de chirurgie orthopédique, traumatologique et plastique pédiatrique, hôpital des enfants, CHU Toulouse, 330, avenue de Grande-Bretagne, 31059, France.

    Papers in Europe PMC
  5. 05
    Ashby E2 papers · 2024

    Department of Paediatric Orthopaedics.

    Papers in Europe PMC
  6. 06
    Cadilhac C2 papers · 2008

    Service de Chirurgie Pédiatrique, Hôpital Morvan, 29200 Brest.

    Papers in Europe PMC
  7. 07
    Cahuzac JP2 papers · 2004
    Papers in Europe PMC
  8. 08
    Deroussen F2 papers · 2019

    Service d'orthopédie pédiatrique, groupe hospitalier Sud, CHU d'Amiens, 80054 Amiens cedex 1, France.

    Papers in Europe PMC
  9. 09
    Di Gennaro GL2 papers · 2022

    Department of Paediatric Orthopedics and Traumatology, Rizzoli Orthopedic Institute, Bologna, Italy.

    Papers in Europe PMC
  10. 10
    Gouron R2 papers · 2019

    Service d'Orthopédie Pédiatrique CHU Amiens Hôpital Nord Place, Victor Pauchet 80054 Amiens Cedex 1, France. gouron.richard@chu-amiens.fr.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Congenital pseudoarthrosis of the clavicle" OR "Congenital pseudoarthrosis of clavicle" OR "Congenital pseudarthrosis of the clavicle" OR "Congenital pseudarthrosis of clavicle"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Clavicle, Pseudarthrosis Of, Congenital

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Congenital pseudoarthrosis of the clavicle" OR "Congenital pseudoarthrosis of clavicle" OR "Congenital pseudarthrosis of the clavicle" OR "Congenital pseudarthrosis of clavicle" OR "Clavicle, Pseudarthrosis Of, Congenital"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T01:21:52.631Z